Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-25 @ 1:46 AM
NCT ID:
NCT01020994
Eligibility Criteria:
Inclusion Criteria:
* Clinically diagnosed super-infected or impetiginized eczema
Exclusion Criteria:
* Patients who have general signs of systemic infections like fever, malaise, lymphangitis or swollen lymph nodes and / or need systemic antibiotic treatment
* Patients who have a bacterial skin infection which, due to depth and severity, could not be appropriately treated with a topical antimicrobial or antiseptic medication
* Diagnose of the following disease:
* Known active tuberculosis or any history of past tuberculosis of skin
* Suspected or proven parasitic infection of the treatment site (e.g. scabies)
* Psoriasis
* Suspected or proven viral infection of skin (e.g. Herpes)
* Localization of the superficial infected eczema:
* Palms of the hands
* Sole of a foot
* Face
* Have received any topical treatment with antibiotics, antimycotics, immunomodulators and corticosteroid preparations within the last 2 weeks before treatment with IMP
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01020994
Study Brief:
Protocol Section:
NCT01020994